![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The spectrophotometric analysis of amniotic fluid is a valuable new laboratory tool for predicting the severity of hemolytic disease in the newborn. Evaluation of the pregnant Rh-negative patient includes this analysis in addition to a carefully obtained obstetrical history, documentation of the husband's genotype, and a Coombs titer. These procedures, repeated as necessary, determine whether or not the pregnancy should be allowed to continue to full term.